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PROJECT BASEBALL I BACKG ROUND IN FORMATION  
Overview of Braves Proposals and Final Offer ($ in bi llions, except per share data)  
Share Price Evolution Since Announcement  
60.00 Braves Jan-10 Proposal $59.741  
58.00 Braves Dec-20 Proposal $58 .86  
56.00 Braves Dec-5 Proposal $57.81  
54.00 Royals $55.97 +19%  
52.00 Braves Oct-20 Proposal  $55.84   
50.00 S&P 500 +6%  
48.00 Braves £47.30 (2%) (GBP)  
$47.17 46.00 Braves AD R $115.21 (2%) (USD)  
44.00 42.00 40.00   
10/20/16 11/6/16 11/23 /16 12 /10/16 12/27/16 1/13 /17  
Braves Final Offer per Royals Share Unaffected Share Price Final Offer1 
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PROJECT BASEBALL II ROYALS STANDALON E VALUATION ANALY SIS  
Standalone Valuat ion Analysis Overview  
Focused on three primary  methodologies  
– Discounted cash flow  (DCF) analy sis  
– Precedent transaction benchmarks in the tobacco space: based on LTM E BITDA multip les applied to Royals 2016E E BITDA  
– Trading comparable benchmarks in the tobacco space: based on 2017E P/E and E BITDA mult iples  
Based on Royals Management projections  
Performed selected analy ses to provide addit ional contex t (for reference only )  
– Royals share price evolution over past year  
– Premia paid in selected precedent transactions  
– Analy st price targets  
LAZARD 5  
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-11.5pts of effective tax rate (c. 25%) $12.35  
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PROJECT BASEBALL III BRAVE S STANDALONE VALUATION ANALY SIS  
1 Braves Standalone DCF Valuation Analysis (as of 12 /31/2016)  
(£ in millions, expect per share data)  
Projected ’17E-’21E  
2017E 2018E 2019E  2020E 2021E TY CAG R  
Revenue £16,316 £16,969  £17,647 £18,353 £19 ,087 £19,087 4 .0%  
% Growth 4.0% 4.0% 4.0% 4.0%  
EBITDA £6,405 £6,769 £7,128 £7,505 £7,900 £7,900 5.4%  
% Margin 39.3% 39.9% 40.4% 40.9% 41 .4% 41.4%  
EBIT 6,040 6,404 6 ,763 7,140 7,535 7,535 5.7%  
% Margin 37.0% 37.7% 38.3% 38.9% 39 .5% 39.5%  
Less: Taxes (1,752) (1,857) (1,961) (2,071) (2,185) (2,185)  
% Tax Rate (29.0%) (29.0%) (29.0%) (29.0%) (29.0%) (29.0%)  
Unlevered Net Income £4,288 £4,547 £4,802 £5,069 £5,350 £5,350 5.7%  
Plus: D&A 365 365  365 365 365 365  
Less: Capex (600) (600) (600) (600) (600) (600)  
Less: Change in NWC (120) (300) (300) (300) (300) (300)  
Less: Pension Expense (626) (328) (250) (250) (250) (250)  
Unlevered FCF £3,307 £3,684 £4,017 £4,284 £4,565 £4,565 8.4%  
PV of Terminal Value Enterprise Value Implied Equity  Value  
PV of FCF’s at TVGR of at  
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PROJECT BASEBALL IV PRO FO RMA FINANCIAL ANALY SI S  
Overview of Has-Gets Analysis Methodo logies  
Royals Shareholder Perspective  
Discounted Cash Flow  
EV / EBITDA Mult iple P/E Mult iple  
HAS GET S  
Cash component of $29.44 per share  
DCF equ ity  value per Royals share as of Equity  component composed of DCF equity  value per pro  
12/31/2016 forma Braves share as of 6/30/2017 (blended WA CC and  
WACC range of 5.00%-6.00% PGR)  
PGR range of (0.5%)-0.5% Discounted to 12/31/2016 using implied blended cost of  
equity  plus value of interim dividends ($0.46 per share in Q1   
of 2017 and $0.46 per share in Q2 of 2017)  
Cash component of $29.44 per share  
Standalone equity  value per share implied by  Equity  component based on blended 2017E EV/E BITDA  
multiple applied to Next 12 Mon ths E BITDA as of 6/30/2017  
current 2017E EV/E BITDA multip le valuation  adjusted to include full run-rate synergies  
range applied to Royals 2017E EBITDA net of the EV bridge Implied multip le range of 10.5x-13.0x  
Mult iple range of 11.0x-13.0x Discounted to 12/31 /2016 using  implied b lended cost of  
equity  plus value of interi  
 
PROJECT BASEBALL IV PRO FO RMA FINANCIAL ANALY SI S  
Summary  of Has-Gets Analysis – Royals Shareholder Perspective  
DCF METHODOLOGY SELE CTED MUL TIPLES METHO DOLOGY  
DCF EV /EBITDA P/E  
 
PROJECT BASEBALL IV PRO FO RMA FINANCIAL ANALY SI S  
Royals Shareholders Has-Gets – D CF- Based Valuation  Analysis  
Royals Shareholder Perspective 
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PROJECT BASEBALL IV PRO FO RMA FINANCIAL ANALY SI S  
Pro Forma DCF Valuation Analysis (Assumes Clos ing as of 6 /30/2017)  
($ in millions, except per share data)  
Management Projections ’17E- ’21E  
2H 2017E 2018E 2019E 2020E 2021E TY CAG R  
Revenue $16,543 $34,299  $35,835 $37,460 $39 ,168 $39,168 4 .5%  
% Growth 4.3% 4.5% 4.5% 4.6% 0.0%  
EBITDA (before synergies) $7,180 $15,125 $16,015 $17,172 $18,323 $18,323 6.7%  
% Margin 43.4% 44.1% 44.7% 45.8% 46 .8% 46.8%  
EBIT (before synergies) 6,891 14,540 15,431 16,581 17,730 17,730 7.0%  
% Margin 41.7% 42.4% 43.1% 44.3% 45 .3% 45.3%  
Synergies, net (250) 0 500 500 500 500  
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PROJECT BASEBALL A  SUPPLEMENTA RY CAPITAL MARKET MATE RIALS  




1.60 1/13 /17  
GBP/USD  
1.52 Since Jan  
1.50 2013 A vg  
1.47 Since Lantern  
Avg  
1.40  
1.35 1-Year Avg.  
1.30  
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PROJECT BASEBALL A  SUPPLEMENTA RY 
 
 
PROJECT BASEBALL A  SUPPLEMENTA RY CAPITAL MARKET MATE RIALS 
 
 
CONFIDENTIAL PRO JECT BA SEBAL L  
 
PROJECT BASEBALL B 
 
Net Income 2,620 5,240 5,652 6,018  6,445 6,867  
% Margin 32.1% 32.1% 33.3% 34.1% 35 .1% 36.0%  
EPS 2.80 3.02 3.24 3.52 3.82  
Diluted Share Coun t 1,874 1,874 1 ,858 1,829 1,796  
Capital Expenditures (300) (600) (600) (600) (600) (600)  
% Sales (3.7%) (3.7%) (3.5%) (3.4%) (3.3%) (3.1%)  
D&A 183 365 365 365 365  365  
Increase in NWC (60) (120) (300) (300) (300) (300)  
% Increase in Sales (0) (7.9%) (45.9%) (44.2%) (42.5%) (40.9%)  
Pension & Restructuring (313) (626) (328) (250) (250) (250)  
Unlevered FCF (ex. income from Ass .) 1,654 3,307 3,684 4,017 4 ,284 4,565  
Share Repurchase — — — 523 1,868 1,995   
Dividends (1,703) (3,406) (3,674) (3,912) (4,189) (4,463)  
DPS ($1.82) ($1.96) ($2.11) ($2.29) ($2.48)  
Debt 18,997 18,195 17, 
 
PROJECT BASEBALL B SUPPLEMENTARY FINANCIAL MATE RIALS  
Royals/Braves Cross Shareholder Analysis  
($ in millions) Shading represents cross holders Royals Rank Investor1 % O /S  
1 Capital Group 5.6% 2 Vanguard 4.5% 3 Blac kRoc k 3.4% 4 Invesco 2.6% 5 State Street 2.2%  
6 Fidel ity  Management & Research 2.1%  
7 Morgan Stanley  1.5%  
8 BNY Mellon 1.3%  
9 J.P. Morgan Chase 1.2%  
10 Franklin Resources 1.2%  
11 Bank of America 1.0%  
12 Federated Investors 0.9%  
13 Evercore Trust Company  0.7%  
14 Janus Capital 0. 6% 
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PROJECT BASEBALL C SUPPLEMENTARY VA LUATION MATE RIALS  
Transaction Sources & Uses  
($ in bil lions, except per share data)  
USES O F FUND S  
SOURCE S OF FUND S  
Offer Price 1 $59.74  
% Premium to Current ($55.97) - 01/13 7%  
% Premium to Unaffected Share Price ($47.17) - 10/20 27% 
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